A Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy of Standard and Low-Dose Hydrochlorothiazide Treatment for Prevention of Recurrent Calcareous Nephrolithiasis (NOSTONE Trial)
Nasser A. Dhayat(University of Bern), Olivier Bonny, Beat Roth(University Hospital of Bern), Daniel G. Fuster(University of Bern), Grazia M. Cereghetti(University Hospital of Bern)
Cited by 0
Related Papers
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
SLC9/NHE gene family, a plasma membrane and organellar family of Na+/H+ exchangers
|Molecular Aspects of Medicine|2013|280
Traditional and emerging roles for the SLC9 Na+/H+ exchangers
|Pflügers Archiv - European Journal of Physiology|2013|187
Mice generated by in vitro fertilization exhibit vascular dysfunction and shortened life span
|Journal of Clinical Investigation|2013|179
Insulin activates Na<sup>+</sup>/H<sup>+</sup>exchanger 3: biphasic response and glucocorticoid dependence
|American Journal of Physiology-Renal Physiology|2002|175